University of Tasmania
Browse

File(s) not publicly available

The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective

journal contribution
posted on 2023-05-17, 09:30 authored by Andrew PalmerAndrew Palmer, Brandt, A
No description available

History

Publication title

Monaldi Archives for Chest Disease

Volume

51

Issue

4

Pagination

279-288

ISSN

1122-0643

Department/School

Menzies Institute for Medical Research

Publisher

PI-ME Editrice

Place of publication

Italy

Repository Status

  • Restricted

Socio-economic Objectives

Evaluation of health and support services not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC